DSGN

NASDAQStock

Design Therapeutics, Inc.

$10.02-0.01 (-0.05%)

52-Week Range

$2.79
$10.97

Key Stats

Market Cap

570.5M

P/E Ratio

Dividend Yield

Beta

1.63

Volume

269.8K

Avg Volume

191.9K

Performance

1M

-0.30%

3M

+9.87%

6M

+70.99%

YTD

+10.11%

1Y

+112.96%

3Y

+42.94%

5Y

-75.85%

Price Chart

ETF Exposure

DSGN is held by 54 ETFs

ETFFund NameWeight
DWASInvesco Dorsey Wright SmallCap Momentum ETF0.38%
SBIOALPS Medical Breakthroughs ETF0.38%
IDNAiShares Genomics Immunology and Healthcare ETF0.33%
IWCiShares Micro-Cap ETF0.05%
SBIO.LInvesco NASDAQ Biotech UCITS ETF0.04%
IBBQInvesco Nasdaq Biotechnology ETF0.04%
BIBProShares - Ultra Nasdaq Biotechnology0.03%
FESMFIDELITY ENHANCED SMALL CAP ETF0.03%
IBBiShares Biotechnology ETF0.03%
AVSCAvantis U.S. Small Cap Equity ETF0.03%
VTWVVanguard Russell 2000 Value ETF0.02%
IWNiShares Russell 2000 Value ETF0.02%
SC0K.DEInvesco Russell 2000 UCITS ETF0.01%
IWMiShares Russell 2000 ETF0.01%
RSSLGlobal X - Russell 2000 ETF0.01%
VTWOVanguard Russell 2000 ETF0.01%
XSU.TOiShares U.S. Small Cap Index ETF (CAD-Hedged)0.01%
R2SC.LState Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)0.01%
SCHASchwab U.S. Small-Cap ETF0.01%
DFASDimensional - US Small Cap ETF0.01%
UWMProShares - Ultra Russell20000.01%
XRS2.DEXtrackers Russell 2000 UCITS ETF 1C0.01%
XRSU.LXtrackers Russell 2000 UCITS ETF 1C0.01%
URTYProShares - UltraPro Russell20000.01%
AVTMAvantis Total Equity Markets ETF 10.00%
DXUVDimensional - US Vector Equity ETF0.00%
ONEQFIDELITY NASDAQ COMPOSITE INDEX ETF0.00%
VXFVanguard Extended Market ETF0.00%
SMMDiShares Russell 2500 ETF0.00%
DCORDimensional - US Core Equity 1 ETF0.00%
DFSUDimensional - US Sustainability Core 1 ETF0.00%
HDGProShares - Hedge Replication ETF0.00%
IWViShares Russell 3000 ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
DFACDimensional - US Core Equity 2 ETF0.00%
DFATDimensional - US Targeted Value ETF0.00%
DFAUDimensional - US Core Equity Market ETF0.00%
DFUSDimensional - US Equity Market ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
Page 1 of 2Next

About DSGN ETF Exposure

Design Therapeutics, Inc. (DSGN) is held by 54 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 570.5M, DSGN is a widely held institutional stock. The stock currently trades at $10.02. Investors can gain exposure to DSGN through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold DSGN, sorted by portfolio weight.